Synthetic dimeric-drug phospholipid: a versatile liposomal platform for cancer therapy-Reference-Cited by-同舟云学术

Synthetic dimeric-drug phospholipid: a versatile liposomal platform for cancer therapy

Published:2020 Issue:55 Volume:56 Page:7621-7624
ISSN:1359-7345
Container-title:Chemical Communications
language:en
Short-container-title:Chem. Commun.

Author:

Ling Longbing¹²³⁴⁵,Yu Haizhou⁶⁴⁵,Ismail Muhammad⁷⁸⁹⁵,Zhu Yanping¹²³⁴⁵,Du Yuan¹²³⁴⁵,Qi Junhui¹²³⁴⁵

Affiliation:

1. Key Laboratory of Molecular Pharmacology and Drug Evaluation (Ministry of Education of China)

2. School of Pharmacy

3. Yantai University

4. Yantai 264005

5. China

6. Yantai Center for Food and Drug Control

7. Henan-Macquarie University Joint Center for Biomedical Innovation School of Life Science

8. Henan University

9. Kaifeng

Abstract

A liposomal platform self-assembled from a novel and universal synthetic dimeric-drug phospholipid.

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,Metals and Alloys,Surfaces, Coatings and Films,General Chemistry,Ceramics and Composites,Electronic, Optical and Magnetic Materials,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2020/CC/D0CC03589K

Reference22 articles.

1. Cancer nanomedicines: So many papers and so few drugs!

2. New Developments in Liposomal Drug Delivery

3. Stable Emulsions Formed by Self-Assembly of Interfacial Networks of Dipeptide Derivatives

4. Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyridine-appended disulfidephospholipids enable exceptionally high drug loading and stability as a robust liposomal platform;Biomaterials Science;2023

2. Advances in nanoscale carrier-based approaches to reduce toxicity and enhance efficacy of podophyllotoxin;Acta Materia Medica;2023

3. ROS-mediated liposomal dexamethasone: a new FA-targeted nanoformulation to combat rheumatoid arthritis via inhibiting iRhom2/TNF-α/BAFF pathways;Nanoscale;2021